Status:
COMPLETED
Effects of N-3 Intake on Lipid Profile, Biochemical and Inflammatory Markers in Subjects with Obesity
Lead Sponsor:
University of Guadalajara
Collaborating Sponsors:
Centro Universitario de Ciencias de la Salud, Mexico
Hospital Civil de Guadalajara
Conditions:
Obesity
Eligibility:
All Genders
25-50 years
Phase:
NA
Brief Summary
Obesity is a chronic disease characterized by the excessive accumulation of adipose tissue that is harmful to health. Dietary habits modification through a caloric restriction, macronutrient distribut...
Detailed Description
A randomized clinical trial was conducted at the Institute of Translational Nutrigenetics and Nutrigenomics of the University of Guadalajara. All participants were recruited through flyers and social ...
Eligibility Criteria
Inclusion
- Subjects of both sexes
- Mestizo from West Mexico
- Age between 30 to 50 years of age
- Sign the Informed Consent
- Diagnostic of Obesity type I and II according to BMI (30 - 40kg / m2)
- Waist circumference (WC) women ≥80cm, men ≥90cm
- Sedentary lifestyle ˂ 150 minutes per week
Exclusion
- Pregnant or breastfeeding women
- Diabetes disease
- Cardiovascular disease
- Any type of cancer disease Tobacco and alcohol (consumption ≥ 40 g of alcohol per day for men and ≥ 20 g for women)
- Participants that consume n-3 supplements, anti-inflammatory medications, or some type of lipid-lowering drugs in the past year
Key Trial Info
Start Date :
January 10 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 15 2019
Estimated Enrollment :
58 Patients enrolled
Trial Details
Trial ID
NCT04901052
Start Date
January 10 2018
End Date
March 15 2019
Last Update
November 15 2024
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Guadalajara
Guadalajara, Jaliscco, Mexico, 44280
2
Erika Martínez-López
Guadalajara, Jalisco, Mexico, 44340